KIMBERLY BIBB: Open Payments
NPI 1336542430 · FERNANDINA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 33 payments from 11 companies in 2025. Trend: 2023 $252 · 2024 $838 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $182 |
| Lilly USA, LLC | 11 | $174 |
| Novo Nordisk Inc | 6 | $105 |
| Exact Sciences Corporation | 4 | $65 |
| ABBVIE INC. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Abbott Laboratories | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: AIRSUPRA, MOUNJARO, Wegovy, Cologuard Collection Kit, UBRELVY, JARDIANCE, KISUNLA, NEXLETOL.
Industry payments across FL — which companies pay providers there.
